Trupanion insider buys signal confidence amid market volatility, as McGibney’s RSU conversions and modest sales hint at potential upside for pet‑health insurance investors.
CEO Tooth Margaret’s recent Trupanion buy signals insider confidence amid sharp decline—an insider buy that may boost sentiment as the pet‑insurance firm scales its claims‑growth platform.
Trupanion COO sells 430 shares via a 10b5‑1 plan at $25.47, a routine diversification move amid a recent 4.5‑point price decline and investor uncertainty.